Table 4.
Susceptibility rates to oral and parenteral antimicrobials of most common uropathogens isolated from urine samples.
| Organism (n; %) | Antimicrobials | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CIP | LVX | NOR | NIT | SXT | AMP | AMC | FOS | PIP | TZP | CFZ | CRO | MRP | IMP | GEN | AMK | |
| E. coli (9344;67.6%) | 76.8 | 77.1 | 76.6 | 95.1 | 72.9 | 48.0 | 77.5 | 97.0 | 51.9 | 95.4 | 84.3 | 90.0 | 100 | 99.9 | 91.0 | 99.6 |
| K. pneumonia (1204;8.7%) | 93.6 | 93.0 | 95.3 | 35.1 | 89.8 | 0 | 81.4 | 81.0 | 61.8 | 92.3 | 78.3 | 87.9 | 99.7 | 99.9 | 92.9 | 97.1 |
| E. faecalis (868;8.3%) | 71.9 | 82.3 | — | 96.1 | — | 96.1 | — | 100.0 | — | — | — | — | — | — | — | — |
| P. mirabilis (723;5.2%) | 62.9 | 75.2 | 78.3 | 0 | 51.5 | 38.9 | 67.0 | 60.8 | 64.8 | 98.9 | 65.4 | 79.0 | 100 | 94.0 | 67.7 | 99.3 |
| P. aeruginosa (345;2.3%) | 57.7 | 58.7 | 60.6 | 0 | 0 | 0 | 0 | 0 | 88.4 | 95.9 | 0 | 0 | 94.7 | 93.3 | 68.0 | 83.7 |
—: not tested; CIP: ciprofloxacin; LVX: levofloxacin; NOR: norfloxacin; NIT: nitrofurantoin; SXT: trimethoprim-sulfamethoxazole; AMP: ampicillin; AMC: amoxicillin/clavulanic acid; FOS: fosfomycin; PIP: piperacillin; TZP: piperacillin/tazobactam; CFZ: cefazolin; CRO: ceftriaxone; MRP: meropenem; IMP: imipenem; GEN: gentamicin; AMK: amikacin.